1. Welcome to the Future

   • Jorge R. Barrio

   Editorial Open access 10 March 2010 Pages: 109 - 109

2. Acquisition Parameters for Oncologic Imaging with a New SPECT/Multislice CT Scanner

   • Rodolfo Núñez
   • William D. Erwin
   • Homer A. Macapinlac

   Review Article 05 January 2010 Pages: 110 - 138

   

3. Additional Value of FDG-PET/CT in Management of “Solitary” Liver Metastases: Preliminary Results of a Prospective Multicenter Study

   • Gaia Grassetto
   • Adriano Fornasiero
   • Domenico Rubello

   Brief Article 22 July 2009 Pages: 139 - 144

   

4. Dynamic Contrast-Enhanced Folate-Receptor-Targeted MR Imaging Using a Gd-loaded PEG-Dendrimer–Folate Conjugate in a Mouse Xenograft Tumor Model

   • Wei-Tsung Chen
   • Dhakshanamurthy Thirumalai
   • Pang-Chyr Yang

   Research Article 28 July 2009 Pages: 145 - 154

   

5. In Vivo Imaging of Sentinel Nodes Using Fluorescent Silica Nanoparticles in Living Mice

   • Yong Hyun Jeon
   • Young-Hwa Kim
   • Keon Wook Kang

   Research Article 15 October 2009 Pages: 155 - 162

   

6. Detection of Experimentally Induced Pulmonary Granuloma Inflammation in Monocyte Chemoattractant Protein-1 Reporter Mice

   • Subbiah Rajasekaran
   • Vivia Yu-Ying Kao
   • Kurt Ming-Chao Lin

   Research Article 06 October 2009 Pages: 163 - 173

   

7. Predicting Early Chemotherapy Response with Technetium-99m Methoxyisobutylisonitrile SPECT/CT in Advanced Non-Small Cell Lung Cancer

   • Tzu-I J. Yang
   • Tjeerd S. Aukema
   • Marcel Verheij

   Research Article 12 September 2009 Pages: 174 - 180

   

8. [¹¹C]Gefitinib ([¹¹C]Iressa): Radiosynthesis, In Vitro Uptake, and In Vivo Imaging of Intact Murine Fibrosarcoma

   • Ming-Rong Zhang
   • Katsushi Kumata
   • Kazutoshi Suzuki

   Research Article 26 September 2009 Pages: 181 - 191

   

9. COMT Val158Met Genotype Does Not Alter Cortical or Striatal Dopamine D2 Receptor Availability In Vivo

   • Mika M. Hirvonen
   • Kjell Någren
   • Jarmo Hietala

   Research Article 01 October 2009 Pages: 192 - 197

   

10. ¹³¹I-Tositumomab (Bexxar®) vs.⁹⁰Y-Ibritumomab (Zevalin®) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma

    • Andrei Iagaru
    • Erik S. Mittra
    • Michael L. Goris

    Research Article 20 June 2009 Pages: 198 - 203

    

11. Incremental Value of Integrated FDG-PET/CT in Evaluating Indeterminate Solitary Pulmonary Nodule for Malignancy

    • Chih-Yung Chang
    • Ching Tzao
    • Ching-Yee Oliver Wong

    Research Article 20 June 2009 Pages: 204 - 209

    

12. Dual Tracer ¹¹C-Choline and FDG-PET in the Diagnosis of Biochemical Prostate Cancer Relapse After Radical Treatment

    • José A. Richter
    • Macarena Rodríguez
    • María J. García-Velloso

    Research Article 19 June 2009 Pages: 210 - 217

    

13. Surface Feature-Guided Mapping of Cerebral Metabolic Changes in Cognitively Normal and Mildly Impaired Elderly

    • Liana G. Apostolova
    • Paul M. Thompson
    • Daniel H. Silverman

    Research Article Open access 28 July 2009 Pages: 218 - 224

    

14. On the Added Value of Baseline FDG-PET in Malignant Lymphoma

    • Henriette Quarles van Ufford
    • Otto Hoekstra
    • John de Klerk

    Research Article Open access 07 October 2009 Pages: 225 - 232